Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
77.46 USD | +1.84% | +22.54% | +0.39% |
05-06 | Argus Adjusts Price Target on Bio-Techne to $95 From $90, Keeps Buy Rating | MT |
05-02 | UBS Adjusts Price Target on Bio-Techne to $90 From $80, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.39% | 11.96B | |
+21.74% | 46.81B | |
-0.97% | 41.37B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.12% | 26.06B | |
-19.37% | 19.13B | |
+31.18% | 12.39B | |
-0.04% | 12.08B | |
+21.07% | 11.56B |
- Stock Market
- Equities
- TECH Stock
- News Bio-Techne Corporation
- Bio Techne : to Collaborate With Narayana Nethralaya to Develop Diagnostics for Ophthalmology Disorders